China Universal Asset Management Company’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Sell
4,631
-1,533
-25% -$92.9K 0.02% 313
2026
Q1
$342K Sell
6,164
-1,348
-18% -$72.5K 0.03% 299
2025
Q4
$364K Sell
7,512
-2,395
-24% -$93.4K 0.03% 285
2025
Q3
$303K Buy
9,907
+4,006
+68% +$91.9K 0.03% 291
2025
Q2
$131K Sell
5,901
-250
-4% -$5.23K 0.01% 342
2025
Q1
$114K Sell
6,151
-301
-5% -$5.02K 0.01% 352
2024
Q4
$85.4K Buy
6,452
+644
+11% +$15.6K 0.01% 411
2024
Q3
$195K Buy
5,808
+2,600
+81% +$88.8K 0.02% 305
2024
Q2
$80.4K Sell
3,208
-1,915
-37% -$44.6K 0.01% 314
2024
Q1
$115K Buy
5,123
+2,051
+67% +$48.6K 0.01% 359
2023
Q4
$65.8K Buy
3,072
+2,390
+350% +$41.2K 0.01% 337
2023
Q3
$12.2K Buy
682
+335
+97% +$6.39K ﹤0.01% 336
2023
Q2
$7.06K Sell
347
-38
-10% -$770 ﹤0.01% 339
2023
Q1
$8.38K Buy
385
+96
+33% +$2.33K ﹤0.01% 317
2022
Q4
$8.96K Buy
289
+24
+9% +$678 ﹤0.01% 237
2022
Q3
$7K Buy
+265
New +$6.21K ﹤0.01% 231

Other funds holding ANAB

China Universal Asset Management Company's ANAB Position: Q2 2026 in Review

China Universal Asset Management Company reduced its AnaptysBio (ANAB) stake by 25% in Q2 2026, selling an estimated $92.9K and leaving 4,631 shares worth $313K. The position accounts for 0.02% of the portfolio, ranked #313.

China Universal Asset Management Company first reported a position in ANAB in Q3 2022 and has held it in 16 quarters since. The position peaked at $364K in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • China Universal Asset Management Company held 4,631 shares of AnaptysBio worth $313K as of Q2 2026.
  • China Universal Asset Management Company sold 1,533 AnaptysBio shares in Q2 2026, an estimated $92.9K.
  • AnaptysBio made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #313 holding.
  • China Universal Asset Management Company first reported a position in AnaptysBio in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's AnaptysBio position peaked at $364K in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.